Europe Oral Vaccines Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Oral Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Oral Vaccines Market Segmentations:

    By Player:

    • EuBiologics

    • Halfkin Bio-Pharmaceuticals

    • Tiantan Biological

    • Bio-Med

    • Valneva

    • Merck

    • Shanghai United Cell

    • Sanofi

    • Bibcol

    • Lanzhou Institute

    • Vabiotech

    • Serum Institute

    • Panacea Biotec Ltd

    • PaxVax

    • GSK

    By Type:

    • Rotavirus Vaccine

    • Cholera Vaccine

    • Oral Polio Vaccine

    • Others

    By End-User:

    • Public

    • Private

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Oral Vaccines Market Size and Growth Rate of Rotavirus Vaccine from 2014 to 2026

    • 1.3.2 Europe Oral Vaccines Market Size and Growth Rate of Cholera Vaccine from 2014 to 2026

    • 1.3.3 Europe Oral Vaccines Market Size and Growth Rate of Oral Polio Vaccine from 2014 to 2026

    • 1.3.4 Europe Oral Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Oral Vaccines Market Size and Growth Rate of Public from 2014 to 2026

    • 1.4.2 Europe Oral Vaccines Market Size and Growth Rate of Private from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oral Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Rotavirus Vaccine

      • 3.4.2 Market Size and Growth Rate of Cholera Vaccine

      • 3.4.3 Market Size and Growth Rate of Oral Polio Vaccine

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Oral Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oral Vaccines for Public

      • 4.4.2 Market Size and Growth Rate of Oral Vaccines for Private

    5 Market Analysis by Major Regions

    • 5.1 Europe Oral Vaccines Production Analysis by Top Regions

    • 5.2 Europe Oral Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Oral Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oral Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Oral Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oral Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oral Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oral Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oral Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oral Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Oral Vaccines Landscape Analysis

    • 7.1 Germany Oral Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Oral Vaccines Landscape Analysis by Major End-Users

    8. UK Oral Vaccines Landscape Analysis

    • 8.1 UK Oral Vaccines Landscape Analysis by Major Types

    • 8.2 UK Oral Vaccines Landscape Analysis by Major End-Users

    9. France Oral Vaccines Landscape Analysis

    • 9.1 France Oral Vaccines Landscape Analysis by Major Types

    • 9.2 France Oral Vaccines Landscape Analysis by Major End-Users

    10. Italy Oral Vaccines Landscape Analysis

    • 10.1 Italy Oral Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Oral Vaccines Landscape Analysis by Major End-Users

    11. Spain Oral Vaccines Landscape Analysis

    • 11.1 Spain Oral Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Oral Vaccines Landscape Analysis by Major End-Users

    12. Poland Oral Vaccines Landscape Analysis

    • 12.1 Poland Oral Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Oral Vaccines Landscape Analysis by Major End-Users

    13. Russia Oral Vaccines Landscape Analysis

    • 13.1 Russia Oral Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Oral Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Oral Vaccines Landscape Analysis

    • 14.1 Switzerland Oral Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Oral Vaccines Landscape Analysis by Major End-Users

    15. Turkey Oral Vaccines Landscape Analysis

    • 15.1 Turkey Oral Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Oral Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Oral Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Oral Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Oral Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Oral Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Oral Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Oral Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Oral Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Oral Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Oral Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Oral Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Oral Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 EuBiologics

      • 19.1.1 EuBiologics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Halfkin Bio-Pharmaceuticals

      • 19.2.1 Halfkin Bio-Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Tiantan Biological

      • 19.3.1 Tiantan Biological Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Bio-Med

      • 19.4.1 Bio-Med Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Valneva

      • 19.5.1 Valneva Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Merck

      • 19.6.1 Merck Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Shanghai United Cell

      • 19.7.1 Shanghai United Cell Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Sanofi

      • 19.8.1 Sanofi Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Bibcol

      • 19.9.1 Bibcol Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Lanzhou Institute

      • 19.10.1 Lanzhou Institute Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Vabiotech

      • 19.11.1 Vabiotech Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Serum Institute

      • 19.12.1 Serum Institute Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Panacea Biotec Ltd

      • 19.13.1 Panacea Biotec Ltd Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 PaxVax

      • 19.14.1 PaxVax Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 GSK

      • 19.15.1 GSK Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 69 Figures and 148 Tables)

    • Figure Product Picture

    • Figure Europe Oral Vaccines Market Size and Growth Rate of Rotavirus Vaccine from 2014 to 2026

    • Figure Europe Oral Vaccines Market Size and Growth Rate of Cholera Vaccine from 2014 to 2026

    • Figure Europe Oral Vaccines Market Size and Growth Rate of Oral Polio Vaccine from 2014 to 2026

    • Figure Europe Oral Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Oral Vaccines Market Size and Growth Rate of Public from 2014 to 2026

    • Figure Europe Oral Vaccines Market Size and Growth Rate of Private from 2014 to 2026

    • Figure Germany Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Oral Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oral Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oral Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Oral Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Rotavirus Vaccine

    • Figure Market Size and Growth Rate of Cholera Vaccine

    • Figure Market Size and Growth Rate of Oral Polio Vaccine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oral Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oral Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Public

    • Figure Market Size and Growth Rate of Private

    • Table Europe Oral Vaccines Production by Major Regions

    • Table Europe Oral Vaccines Production Share by Major Regions

    • Figure Europe Oral Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Oral Vaccines Consumption by Major Regions

    • Table Europe Oral Vaccines Consumption Share by Major Regions

    • Table Germany Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table France Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oral Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oral Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oral Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oral Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Oral Vaccines Consumption by Types from 2014 to 2026

    • Table UK Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Oral Vaccines Consumption by Types from 2014 to 2026

    • Table France Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Oral Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of EuBiologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

    • Figure Sales and Growth Rate Analysis of EuBiologics

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Product and Service Introduction of EuBiologics

    • Table Company Profile and Development Status of Halfkin Bio-Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Halfkin Bio-Pharmaceuticals

    • Table Product and Service Introduction of Halfkin Bio-Pharmaceuticals

    • Table Company Profile and Development Status of Tiantan Biological

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiantan Biological

    • Figure Sales and Growth Rate Analysis of Tiantan Biological

    • Figure Revenue and Market Share Analysis of Tiantan Biological

    • Table Product and Service Introduction of Tiantan Biological

    • Table Company Profile and Development Status of Bio-Med

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Med

    • Figure Sales and Growth Rate Analysis of Bio-Med

    • Figure Revenue and Market Share Analysis of Bio-Med

    • Table Product and Service Introduction of Bio-Med

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Shanghai United Cell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai United Cell

    • Figure Sales and Growth Rate Analysis of Shanghai United Cell

    • Figure Revenue and Market Share Analysis of Shanghai United Cell

    • Table Product and Service Introduction of Shanghai United Cell

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Bibcol

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bibcol

    • Figure Sales and Growth Rate Analysis of Bibcol

    • Figure Revenue and Market Share Analysis of Bibcol

    • Table Product and Service Introduction of Bibcol

    • Table Company Profile and Development Status of Lanzhou Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute

    • Figure Sales and Growth Rate Analysis of Lanzhou Institute

    • Figure Revenue and Market Share Analysis of Lanzhou Institute

    • Table Product and Service Introduction of Lanzhou Institute

    • Table Company Profile and Development Status of Vabiotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vabiotech

    • Figure Sales and Growth Rate Analysis of Vabiotech

    • Figure Revenue and Market Share Analysis of Vabiotech

    • Table Product and Service Introduction of Vabiotech

    • Table Company Profile and Development Status of Serum Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute

    • Figure Sales and Growth Rate Analysis of Serum Institute

    • Figure Revenue and Market Share Analysis of Serum Institute

    • Table Product and Service Introduction of Serum Institute

    • Table Company Profile and Development Status of Panacea Biotec Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec Ltd

    • Figure Sales and Growth Rate Analysis of Panacea Biotec Ltd

    • Figure Revenue and Market Share Analysis of Panacea Biotec Ltd

    • Table Product and Service Introduction of Panacea Biotec Ltd

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.